Skip to content

Clinical trials

Phase 3 Lymphoma, Non-Hodgkin trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 3 Country / region: Netherlands Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20081
20101
20121
20161
20172
20181
20192
20212
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting5
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genmab3
European Organisation for Research and Treatment of Cancer - EORTC2
Pharmacyclics LLC.2
Bayer1
BeOne Medicines1
Celgene1
Genentech, Inc.1
Genzyme, a Sanofi Company1
Hoffmann-La Roche1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin19
Lymphoma, Follicular8
Lymphoma5
Lymphoma, Large B-Cell, Diffuse5
Lymphoma, Mantle-Cell5
Neoplasms4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, B-Cell, Marginal Zone3
Multiple Myeloma3
Recurrence3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.